• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纽约市的羟考酮滥用:静脉注射和鼻内使用者的特征。

Oxycodone abuse in New York City: characteristics of intravenous and intranasal users.

机构信息

Division on Substance Abuse, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA.

出版信息

Am J Addict. 2011 May-Jun;20(3):190-5. doi: 10.1111/j.1521-0391.2011.00120.x. Epub 2011 Mar 8.

DOI:10.1111/j.1521-0391.2011.00120.x
PMID:21477046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3320719/
Abstract

This pilot study sought to characterize typical nonmedical oxycodone use in the New York Metropolitan area. Accordingly, a clinical interview was administered to 25 intranasal (IN) and 25 intravenous (IV) oxycodone abusers to capture demographics and patterns of use within the region. IN and IV abusers shared a number of similar characteristics including age, proportion of men and women, criminal history, drug use history, and current recreational drug use. However, the two populations also differed in a number of aspects. IV oxycodone users had lower rates of employment, earlier onset of illicit drug use, and more current heroin use. Although IN users reported somewhat more frequent use of oxycodone weekly, IV users were more likely to supplement their oxycodone use with other opioid drugs, most notably heroin. Additional research is needed to confirm these observed differences, yet these data may assist treatment efforts by providing information to guide targeted treatment and population-specific interventions.

摘要

这项初步研究旨在描述纽约大都市区典型的非医疗用羟考酮使用情况。为此,对 25 名鼻内(IN)和 25 名静脉内(IV)羟考酮滥用者进行了临床访谈,以获取该地区的人口统计数据和使用模式。IN 和 IV 滥用者在许多方面具有相似的特征,包括年龄、男女比例、犯罪史、药物使用史和当前的娱乐性药物使用。然而,这两个群体在许多方面也存在差异。IV 羟考酮使用者的就业率较低,非法药物使用的起始时间较早,目前使用海洛因的比例较高。尽管 IN 使用者报告每周使用羟考酮的频率略高,但 IV 使用者更有可能用其他阿片类药物来补充羟考酮的使用,其中最常见的是海洛因。需要进一步的研究来证实这些观察到的差异,但这些数据可以通过提供信息来指导有针对性的治疗和特定人群的干预,从而为治疗工作提供帮助。

相似文献

1
Oxycodone abuse in New York City: characteristics of intravenous and intranasal users.纽约市的羟考酮滥用:静脉注射和鼻内使用者的特征。
Am J Addict. 2011 May-Jun;20(3):190-5. doi: 10.1111/j.1521-0391.2011.00120.x. Epub 2011 Mar 8.
2
From oxycodone to heroin: two cases of transitioning opioid use in young Australians.从羟考酮到海洛因:两名澳大利亚年轻人的阿片类药物使用转变案例。
Drug Alcohol Rev. 2014 Jan;33(1):102-4. doi: 10.1111/dar.12093. Epub 2013 Nov 21.
3
Intravenous abuse potential study of oxycodone alone or in combination with naltrexone in nondependent recreational opioid users.羟考酮单独使用或与纳曲酮联合使用在非依赖型娱乐性阿片类药物使用者中的静脉滥用潜力研究。
Am J Drug Alcohol Abuse. 2016 Sep;42(5):539-549. doi: 10.3109/00952990.2016.1167215. Epub 2016 May 21.
4
Intranasal abuse potential of an abuse-deterrent oxycodone formulation compared to oxycodone immediate release and placebo in nondependent, recreational opioid users.在非依赖型娱乐性阿片类药物使用者中,与速释羟考酮和安慰剂相比,一种具有滥用威慑作用的羟考酮制剂的鼻内滥用可能性。
J Opioid Manag. 2017 Nov/Dec;13(6):449-464. doi: 10.5055/jom.2017.0421.
5
Intranasal administration of crushed ALO-02 (extended-release oxycodone with sequestered naltrexone): A randomized, controlled abuse-potential study in nondependent recreational opioid users.鼻内给予碾碎的ALO-02(含缓释纳曲酮的缓释羟考酮):一项针对非依赖型娱乐性阿片类药物使用者的随机对照滥用可能性研究。
J Clin Pharmacol. 2015 Dec;55(12):1351-61. doi: 10.1002/jcph.552. Epub 2015 Jul 2.
6
A nasal abuse potential randomized clinical trial of REMOXY® ER, a high-viscosity extended-release oxycodone formulation.一项关于高粘度缓释羟考酮制剂REMOXY® ER鼻腔滥用可能性的随机临床试验。
J Opioid Manag. 2018 Nov/Dec;14(6):437-443. doi: 10.5055/jom.2018.0476.
7
Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse-deterrent controlled-release tablets in recreational opioid users.盐酸羟考酮控释片碾碎后经鼻给药在娱乐性阿片类药物使用者中的滥用潜力、药代动力学、药效学及安全性
J Clin Pharmacol. 2014 Apr;54(4):468-77. doi: 10.1002/jcph.235. Epub 2013 Dec 11.
8
Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies.静脉注射阿片类药物奥施康定、氢可酮和吗啡在娱乐性阿片类药物使用者中的滥用潜力和相对效价。
Psychopharmacology (Berl). 2010 Oct;212(2):193-203. doi: 10.1007/s00213-010-1942-4. Epub 2010 Jul 28.
9
Key characteristics and habits of the recreational opioid user.娱乐性阿片类药物使用者的关键特征和习惯。
J Opioid Manag. 2019 Nov/Dec;15(6):507-520. doi: 10.5055/jom.2019.0542.
10
Abuse potential of intravenous oxycodone/naloxone solution in nondependent recreational drug users.非依赖型娱乐性药物使用者静脉注射羟考酮/纳洛酮溶液的滥用潜力。
Clin Drug Investig. 2014 Jun;34(6):421-9. doi: 10.1007/s40261-014-0192-3.

引用本文的文献

1
Comparing withdrawal- and anxiety-like behaviors following oral and subcutaneous oxycodone administration in C57BL/6 mice.比较 C57BL/6 小鼠口服和皮下给予羟考酮后戒断和焦虑样行为。
Behav Pharmacol. 2024 Aug 1;35(5):269-279. doi: 10.1097/FBP.0000000000000780. Epub 2024 Jun 3.
2
Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder.治疗羟考酮使用障碍候选疫苗的临床前安全性和毒理学特征。
Vaccine. 2022 May 20;40(23):3244-3252. doi: 10.1016/j.vaccine.2022.03.053. Epub 2022 Apr 22.
3
The American Opioid Epidemic in Special Populations: Five Examples.特殊人群中的美国阿片类药物流行:五个实例
NAM Perspect. 2020 Oct 26;2020. doi: 10.31478/202010b. eCollection 2020.
4
Nonclinical safety assessment of PF614: A novel TAAP prodrug of oxycodone for chronic pain indication.PF614 的非临床安全性评估:一种新型 TAAP 前药奥施康定用于慢性疼痛适应症。
Regul Toxicol Pharmacol. 2019 Nov;108:104433. doi: 10.1016/j.yrtph.2019.104433. Epub 2019 Jul 27.
5
A qualitative study of persons who inject drugs but who have never helped others with first injections: how their views on helping contrast with the views of persons who have helped with first injections, and implications for interventions.一项对从未帮助他人进行首次注射的注射吸毒者的定性研究:他们对帮助的看法与帮助他人进行首次注射者的看法有何不同,以及对干预措施的影响。
Harm Reduct J. 2018 Aug 28;15(1):43. doi: 10.1186/s12954-018-0250-x.
6
Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose.阻断白细胞介素 4 可增强疫苗治疗阿片类药物滥用和预防阿片类药物过量的效果。
Sci Rep. 2018 Apr 3;8(1):5508. doi: 10.1038/s41598-018-23777-6.
7
Opioid Dose- and Route-Dependent Efficacy of Oxycodone and Heroin Vaccines in Rats.阿片类药物剂量和途径依赖性羟考酮和海洛因疫苗在大鼠中的疗效。
J Pharmacol Exp Ther. 2018 May;365(2):346-353. doi: 10.1124/jpet.117.247049. Epub 2018 Mar 13.
8
Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse.羟考酮疫苗的安全性与有效性:应对阿片类药物滥用引发的一些独特考量。
PLoS One. 2017 Dec 1;12(12):e0184876. doi: 10.1371/journal.pone.0184876. eCollection 2017.
9
Prescription opioid use: Patient characteristics and misuse in community pharmacy.处方阿片类药物的使用:社区药房中的患者特征与滥用情况
J Am Pharm Assoc (2003). 2016 May-Jun;56(3):248-256.e6. doi: 10.1016/j.japh.2016.02.012. Epub 2016 Mar 24.
10
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use.非医疗处方阿片类药物使用与海洛因使用之间的关系。
N Engl J Med. 2016 Jan 14;374(2):154-63. doi: 10.1056/NEJMra1508490.

本文引用的文献

1
Prescription opioid aberrant behaviors: a pilot study of sex differences.处方阿片类药物异常行为:一项关于性别差异的初步研究。
Clin J Pain. 2009 Jul-Aug;25(6):477-84. doi: 10.1097/AJP.0b013e31819c2c2f.
2
Changing patterns in opioid addiction: characterizing users of oxycodone and other opioids.阿片类药物成瘾模式的变化:对羟考酮及其他阿片类药物使用者的特征分析
Can Fam Physician. 2009 Jan;55(1):68-9, 69.e1-5.
3
Correlates of extramedical use of OxyContin versus other analgesic opioids among the US general population.美国普通人群中奥施康定与其他镇痛类阿片药物非医疗用途的相关因素。
Drug Alcohol Depend. 2009 Jan 1;99(1-3):58-67. doi: 10.1016/j.drugalcdep.2008.06.013. Epub 2008 Aug 15.
4
Internet-based survey of nonmedical prescription opioid use in the United States.美国基于互联网的非医疗处方阿片类药物使用情况调查。
Clin J Pain. 2008 Jul-Aug;24(6):528-35. doi: 10.1097/AJP.0b013e318167a087.
5
The controversy surrounding OxyContin abuse: issues and solutions.奥施康定滥用争议:问题与解决方案。
Ther Clin Risk Manag. 2005 Jun;1(2):77-82. doi: 10.2147/tcrm.1.2.77.62911.
6
Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates.美国成年人中对处方阿片类药物的非医疗使用、滥用和依赖:与精神疾病、医疗状况及物质使用的相关性
Drug Alcohol Depend. 2008 Apr 1;94(1-3):38-47. doi: 10.1016/j.drugalcdep.2007.09.018. Epub 2007 Dec 11.
7
Prescription OxyContin abuse among patients entering addiction treatment.进入成瘾治疗的患者中处方类羟考酮滥用情况。
Am J Psychiatry. 2007 Nov;164(11):1750-6. doi: 10.1176/appi.ajp.2007.07050252.
8
Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States.美国农村、郊区和城市地区阿片类镇痛药的治疗用途与滥用之间的关系。
Pharmacoepidemiol Drug Saf. 2007 Aug;16(8):827-40. doi: 10.1002/pds.1452.
9
Medications of abuse in pain management.疼痛管理中滥用的药物。
Curr Opin Anaesthesiol. 2007 Aug;20(4):319-24. doi: 10.1097/ACO.0b013e32814b1626.
10
Prescription opioid abuse among enrollees into methadone maintenance treatment.接受美沙酮维持治疗的人员中处方阿片类药物滥用情况。
Drug Alcohol Depend. 2007 Sep 6;90(1):64-71. doi: 10.1016/j.drugalcdep.2007.02.012. Epub 2007 Mar 26.